Lundhus E, Gottrup F
Department of Surgery, Vejle County Hospital, Denmark.
Eur J Surg. 1993 Oct;159(10):555-8.
To evaluate the long term results after primary closure of perianal abscess and pilonidal sinus.
Follow up by questionnaire and study of casenotes.
University hospital and district hospital.
88 Patients who had previously been in a prospective random control trial of two regimens of antibiotic treatment (ampicillin and metronidazole for one compared with four days) before incision, curettage, and primary closure of perianal abscess or pilonidal sinus.
Recurrence rate and outcome.
32 Patients had perianal abscesses of which 31 (97%) healed primarily (95% confidence interval [CI] 84 to 100%) with 4 recurrences (13%, 95% CI 2 to 24%). 56 Patients had pilonidal sinuses or abscesses of which 46 (82%) healed primarily (95% CI 70 to 91%) with 14 recurrences (30%, 95% CI 16 to 40%). There were no significant differences between the two antibiotic regimens. The mean followup was 53 months. Two patients had died, both had had perianal abscesses. Pilonidal sinuses tended to recur during the first year, whereas pilonidal abscesses recurred after a lapse of two years or more. Half the patients who had had previous operations for the same complications, compared with a third who were being operated on for the first time.
A one day course of ampicillin and metronidazole is not associated with any more complications than a four day course. Perianal abscesses respond well to primary closure, but management of pilonidal abscesses and sinuses is more difficult.
评估肛周脓肿和藏毛窦一期缝合后的长期效果。
通过问卷调查和病历研究进行随访。
大学医院和地区医院。
88例患者,这些患者之前在一项前瞻性随机对照试验中,接受了两种抗生素治疗方案(氨苄青霉素和甲硝唑,一种为四天疗程,另一种为一天疗程),之后进行了肛周脓肿或藏毛窦的切开、刮除及一期缝合。
复发率和治疗结果。
32例患者患有肛周脓肿,其中31例(97%)一期愈合(95%置信区间[CI]84%至100%),4例复发(13%,95%CI 2%至24%)。56例患者患有藏毛窦或藏毛脓肿,其中46例(82%)一期愈合(95%CI 70%至91%),14例复发(30%,95%CI 16%至40%)。两种抗生素治疗方案之间无显著差异。平均随访时间为53个月。2例患者死亡,均患有肛周脓肿。藏毛窦倾向于在第一年复发,而藏毛脓肿在两年或更长时间后复发。有一半的患者曾因相同并发症接受过手术,相比之下,首次接受手术的患者中有三分之一。
与四天疗程相比,一天疗程的氨苄青霉素和甲硝唑不会增加更多并发症。肛周脓肿对一期缝合反应良好,但藏毛脓肿和藏毛窦的治疗更困难。